Search research articles
Contact Us
Filters
Showing results (1-10 of 441) with videos related to
Page
of 45
Sort By:
The Lancet. Neurology
|
March 21, 2026
Biologically informed blood testing in Alzheimer's disease
Nicholas J Ashton
Ebiomedicine
|
January 8, 2025
A blood test for Alzheimer's disease: a decade of progress and success
Nicholas J Ashton, Henrik Zetterberg
Electrophoresis
|
November 20, 2012
Finding a pathological diagnosis for Alzheimer's disease: are inflammatory molecules the answer?
Manraj S Bhamra, Nicholas J Ashton
Brain : a Journal of Neurology
|
October 21, 2021
Plasma sTREM2: a potential marker of cerebrovascular injury in neurodegenerative disorders
Elena Rodriguez-Vieitez, Nicholas J Ashton
Ebiomedicine
|
June 16, 2021
Spitting image: can saliva biomarkers reflect Alzheimer's disease?
Nicholas J Ashton, Kaj Blennow, Henrik Zetterberg
Journal of Alzheimer'S Disease : JAD
|
September 9, 2025
Integrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers
Burak Arslan, Henrik Zetterberg, Nicholas J Ashton
Clinical Chemistry and Laboratory Medicine
|
January 22, 2024
Blood-based biomarkers in Alzheimer's disease - moving towards a new era of diagnostics
Burak Arslan, Henrik Zetterberg, Nicholas J Ashton
Critical Care (London, England)
|
March 26, 2022
Brain Injury Biomarkers for Predicting Outcome After Cardiac Arrest
Jaana Humaloja, Nicholas J Ashton, Markus B Skrifvars
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
March 5, 2021
Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre-analytical conditions
Joel Simrén, Nicholas J Ashton, Kaj Blennow, et al.
Neurology and Therapy
|
December 14, 2019
Salivary Biomarkers for Alzheimer's Disease and Related Disorders
Nicholas J Ashton, Mark Ide, Henrik Zetterberg, et al.
Page
of 45
Search research articles
Search
Showing results (1-10 of 441) with videos related to
Sort By:
Page
of 45
The Lancet. Neurology
|
March 21, 2026
Biologically informed blood testing in Alzheimer's disease
Nicholas J Ashton
Ebiomedicine
|
January 8, 2025
A blood test for Alzheimer's disease: a decade of progress and success
Nicholas J Ashton, Henrik Zetterberg
Electrophoresis
|
November 20, 2012
Finding a pathological diagnosis for Alzheimer's disease: are inflammatory molecules the answer?
Manraj S Bhamra, Nicholas J Ashton
Brain : a Journal of Neurology
|
October 21, 2021
Plasma sTREM2: a potential marker of cerebrovascular injury in neurodegenerative disorders
Elena Rodriguez-Vieitez, Nicholas J Ashton
Ebiomedicine
|
June 16, 2021
Spitting image: can saliva biomarkers reflect Alzheimer's disease?
Nicholas J Ashton, Kaj Blennow, Henrik Zetterberg
Journal of Alzheimer'S Disease : JAD
|
September 9, 2025
Integrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers
Burak Arslan, Henrik Zetterberg, Nicholas J Ashton
Clinical Chemistry and Laboratory Medicine
|
January 22, 2024
Blood-based biomarkers in Alzheimer's disease - moving towards a new era of diagnostics
Burak Arslan, Henrik Zetterberg, Nicholas J Ashton
Critical Care (London, England)
|
March 26, 2022
Brain Injury Biomarkers for Predicting Outcome After Cardiac Arrest
Jaana Humaloja, Nicholas J Ashton, Markus B Skrifvars
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
March 5, 2021
Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre-analytical conditions
Joel Simrén, Nicholas J Ashton, Kaj Blennow, et al.
Neurology and Therapy
|
December 14, 2019
Salivary Biomarkers for Alzheimer's Disease and Related Disorders
Nicholas J Ashton, Mark Ide, Henrik Zetterberg, et al.
Page
of 45